![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
P Werner, N Hussy, G Buell, KA Jones and RA North
Glaxo Institute for Molecular Biology, Plan-les-Ouates, Geneva, Switzerland.
Human D2, D3, D4 and dopamine receptors were individually coexpressed in Xenopus oocytes with a G protein-regulated inwardly rectifying potassium channel (GIRK1). At -100 mV in 96 mM potassium, dopamine (0.1- 100 nM) evoked an inward current; the current showed inward rectification, reversed polarity at 0 mV, and was blocked by barium (50% inhibition by 10 microM). The concentrations of dopamine activating 50% of the maximal current (EC50) were not different (2-4 nM) for D2, D3, and D4 receptors, but the maximal current was 3-fold larger for D2 and D4 than for D3 receptors. Dopamine evoked reproducible inward currents at D2 and D4 receptors when applied repeatedly, but second responses could not be observed in oocytes expressing D3 receptors. 7-Hydroxy-N,N-di-n-propyl-2-aminotetralin mimicked the effect of dopamine (EC50 of approximately 2, approximately 3, and approximately 19 nM at D2, D3, and D4, respectively). (-) Sulpiride reversibly blocked the dopamine-induced current with IC50 values of 5, 300, and 2000 nM for D2, D3, and D4 receptors, respectively. Dopamine was ineffective in oocytes injected 2 hr previously with pertussis toxin. We concluded that all three D2-like dopamine receptors share the potential to activate inwardly rectifying potassium channels.
This article has been cited by other articles:
|
|
 |
|
  J. McDaid, M. A. McElvain, and M. S. Brodie Ethanol Effects on Dopaminergic Ventral Tegmental Area Neurons During Block of Ih: Involvement of Barium-Sensitive Potassium Currents J Neurophysiol, September 1, 2008; 100(3): 1202 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Wanat, F. W. Hopf, G. D. Stuber, P. E. M. Phillips, and A. Bonci Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih J. Physiol., April 15, 2008; 586(8): 2157 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Demiralp, C. S. Herrmann, M. E. Erdal, T. Ergenoglu, Y. H. Keskin, M. Ergen, and H. Beydagi DRD4 and DAT1 Polymorphisms Modulate Human Gamma Band Responses Cereb Cortex, May 1, 2007; 17(5): 1007 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zeng, D. Wang, Z. Yang, Z. Wang, L. D. Asico, C. S. Wilcox, G. M. Eisner, W. J. Welch, R. A. Felder, and P. A. Jose Dopamine D1 Receptor Augmentation of D3 Receptor Action in Rat Aortic or Mesenteric Vascular Smooth Muscles Hypertension, March 1, 2004; 43(3): 673 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Appel, Z. Liu, M. A. McElvain, and M. S. Brodie Ethanol Excitation of Dopaminergic Ventral Tegmental Area Neurons Is Blocked by Quinidine J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 437 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lavine, N. Ethier, J. N. Oak, L. Pei, F. Liu, P. Trieu, R. V. Rebois, M. Bouvier, T. E. Hebert, and H. H. M. Van Tol G Protein-coupled Receptors Form Stable Complexes with Inwardly Rectifying Potassium Channels and Adenylyl Cyclase J. Biol. Chem., November 22, 2002; 277(48): 46010 - 46019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, P. Zhong, and Z. Yan Dopamine D4 Receptors Modulate GABAergic Signaling in Pyramidal Neurons of Prefrontal Cortex J. Neurosci., November 1, 2002; 22(21): 9185 - 9193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Kuzhikandathil and G. S. Oxford Classic D1 Dopamine Receptor Antagonist R-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) Directly Inhibits G Protein-Coupled Inwardly Rectifying Potassium Channels Mol. Pharmacol., July 1, 2002; 62(1): 119 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Kilts, H. S. Connery, E. G. Arrington, M. M. Lewis, C. P. Lawler, G. S. Oxford, K. L. O'Malley, R. D. Todd, B. L. Blake, D. E. Nichols, et al. Functional Selectivity of Dopamine Receptor Agonists. II. Actions of Dihydrexidine in D2L Receptor-Transfected MN9D Cells and Pituitary Lactotrophs J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1179 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Prasad and S. G. Amara The Dopamine Transporter in Mesencephalic Cultures Is Refractory to Physiological Changes in Membrane Voltage J. Neurosci., October 1, 2001; 21(19): 7561 - 7567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Price and Q. J. Pittman Dopamine D4 Receptor Activation Inhibits Presynaptically Glutamatergic Neurotransmission in the Rat Supraoptic Nucleus J Neurophysiol, September 1, 2001; 86(3): 1149 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Gregerson, T. P. Flagg, T. J. O'Neill, M. Anderson, O. Lauring, J. S. Horel, and P. A. Welling Identification of G Protein-Coupled, Inward Rectifier Potassium Channel Gene Products from the Rat Anterior Pituitary Gland Endocrinology, July 1, 2001; 142(7): 2820 - 2832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rubinstein, C. Cepeda, R. S. Hurst, J. Flores-Hernandez, M. A. Ariano, T. L. Falzone, L. B. Kozell, C. K. Meshul, J. R. Bunzow, M. J. Low, et al. Dopamine D4 Receptor-Deficient Mice Display Cortical Hyperexcitability J. Neurosci., June 1, 2001; 21(11): 3756 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Mayfield and N. R. Zahniser Dopamine D2 Receptor Regulation of the Dopamine Transporter Expressed in Xenopus laevis Oocytes Is Voltage-Independent Mol. Pharmacol., January 1, 2001; 59(1): 113 - 121. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Millan, A. Gobert, A. Newman-Tancredi, F. Lejeune, D. Cussac, J.-M. Rivet, V. Audinot, T. Dubuffet, and G. Lavielle S33084, a Novel, Potent, Selective, and Competitive Antagonist at Dopamine D3-Receptors: I. Receptorial, Electrophysiological and Neurochemical Profile Compared with GR218,231 and L741,626 J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1048 - 1062. [Abstract] [Full Text]
|
|
|
|
|
|
B. L. Wiens, C. S. Nelson, and K. A. Neve Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2S Dopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations Mol. Pharmacol., August 1, 1998; 54(2): 435 - 444. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Levant The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance Pharmacol. Rev., September 1, 1997; 49(3): 231 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Watts and K. A. Neve Activation of Type II Adenylate Cyclase by D2 and D4 but Not D3 Dopamine Receptors Mol. Pharmacol., August 1, 1997; 52(2): 181 - 186. [Abstract] [Full Text]
|
|
|
|
|
|
A. Newman-Tancredi, V. Audinot, C. Chaput, and L.V. a. M. J. Millan [35S]Guanosine-5'-O-(3-thio)triphosphate Binding as a Measure of Efficacy at Human Recombinant Dopamine D4.4 Receptors: Actions of Antiparkinsonian and Antipsychotic Agents J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 181 - 191. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
